Nilsson B, Friman S, Wallin M, Gustafsson B, Delbro D
Department of Surgery, Sahlgrenska University Hospital, Göteborg, Sweden.
Transpl Int. 2000;13 Suppl 1:S558-61. doi: 10.1007/s001470050402.
We investigated the involvement of adenosine in ischemic preconditioning (IPC) by the unspecific antagonist, 8-phenyltheophylline (8-PT). Anesthetized Wistar rats were treated as follows: 1. non-ischemic controls, 2. ischemic controls: 60 min of clamping of the common hepatic artery followed by 60 min reperfusion, 3. IPC: 10 min ischemia followed by 15 min reperfusion, prior to the identical ischemia-reperfusion (IR) period as in group 2, 4. 8-PT + IPC: 8-PT 10 mg/kg i.v. was given 10 min prior to the identical procedure as in group 3. The peripheral liver blood flow was monitored by laser-Doppler flowmetry. Blood alanine aminotransferase (ALT) was analyzed once every 60 min. IPC significantly reduced impairment of liver blood flow, as well as ALT increase during reperfusion. This effect was abolished by pretreatment with 8-PT. Adenosine appears to be a crucial effector in IPC. Clinical studies need to be undertaken to explore a possible effect of IPC in liver transplantation.
我们通过非特异性拮抗剂8-苯基茶碱(8-PT)研究了腺苷在缺血预处理(IPC)中的作用。将麻醉的Wistar大鼠按以下方式处理:1. 非缺血对照组;2. 缺血对照组:夹闭肝总动脉60分钟,随后再灌注60分钟;3. IPC组:在与第2组相同的缺血-再灌注(IR)期之前,先进行10分钟缺血,随后再灌注15分钟;4. 8-PT + IPC组:在与第3组相同的操作前10分钟静脉注射10 mg/kg的8-PT。通过激光多普勒血流仪监测肝外周血流量。每60分钟分析一次血液丙氨酸转氨酶(ALT)。IPC显著减轻了肝血流的损伤以及再灌注期间ALT的升高。用8-PT预处理可消除这种作用。腺苷似乎是IPC中的关键效应因子。需要进行临床研究以探索IPC在肝移植中的可能作用。